MoneyWorks4Me

Lupin submits copy of revised press release

01 Dec 2016 Evaluate

Lupin vide its letter dated December 01, 2016 has submitted a copy of Revised Press Release as regards expansion of partnership with Eli Lilly and Company (India) (Lilly), to market and sell Lillys rapid-acting Insulin analog Lispro under the brand name Eglucent.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..